ST凯利：于涌金投资控股有限公司要约收购期限届满，公司股票8月18日开市起停牌

Group 1 - ST凯利 announced a tender offer from Yongjin Investment for 71.70 million shares at a price of 5.18 yuan per share, representing 10% of the company's total equity [1] - The tender offer period ended on August 15, 2025, and the company has applied for a trading suspension starting August 18, 2025, pending confirmation of the offer results [1] - As of the announcement, ST凯利's revenue composition for 2024 is as follows: 56.82% from medical device manufacturing, 26.48% from instrument disinfection services, 14.48% from medical device trading, and 2.21% from other businesses [1] Group 2 - The current market capitalization of ST凯利 is 4.4 billion yuan [2]